FDA Approves Lenvima (lenvatinib) for Thyroid Cancer
The US Food and Drug Administration (FDA) has approved Lenvima (linvatinib) for a type of thyroid cancer.
FDA Approves Nexavar for Advanced Thyroid Cancer
The US Food and Drug Administration (FDA) has approved Nexavar (sorafenib) to treat some people with advanced thyroid cancer.
Report Studies Link between World Trade Center Exposure and Cancer Risk
A study of people exposed to Ground Zero has found that early responders and recovery workers at site of the World Trade Center terrorist attack do not appear to have an increased risk of cancer overall thus far.
New Test May Reduce Unnecessary Thyroid Cancer Surgeries
A new test for thyroid cancer may help doctors make more accurate diagnoses, cutting down on unnecessary surgeries.
Annual Report: More Than a Million Cancer Deaths Avoided in 2 Decades
Newly published statistics from the American Cancer Society show that cancer death rates in the U.S. continue to decrease.